Indication
Acute Renal Rejection
1 clinical trial
1 product
Clinical trial
Assessment of Association Between 3rd Dose of mRNA Vaccine and Risk of SARS-CoV-2 Infection in Kidney Transplant Recipients, Safety and Immunogenicity Assessment.Status: Active (not recruiting), Estimated PCD: 2024-12-04
Product
mRNA vaccine booster dose